Dr Reddy’s acquires Habitrol brand

"With this closure, the company has assumed responsibility for the product and will commence shipments of the product in the market shortly," DRL said.

City-based drugmaker Dr Reddy’s Laboratories has acquired Habitrol brand, a nicotine replacement therapy transdermal patch, from NovartisBSE -0.74 % Consumer Health Inc.

According to a statement issued by the drug major, the acquisition of Habitrol brand (an over-the-counter nicotine replacement therapy transdermal patch) from Novartis Consumer Health Inc was done following issuance of the proposed consent order from the US Federal by TotalPlu ..

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s